Resmed Inc (NYSE: RMD) stock closed at $182.20 on 6/24/24 after a major decline of -11.5%. Moreover, trading volume in this decline was exceptionally high at 346% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -14.2% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, RMD is expected to continue to be a modest Value Builder.
Resmed has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Resmed has a very low Appreciation Score of 10 but a good Power Rating of 77, producing the Low Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment